"Yikes! ALDX is drowning in lawsuits after that brutal FDA rejection. 📉 The stock’s recent pop (RSI still lukewarm at 44) feels like a dead-cat bounce—volume spikes scream panic, not conviction. 9-period EMA barely clinging above the 21? Weak sauce. Until the legal dust settles, this is a hard SELL. #ToxicStock 🚨"

"Yikes, ALDX is drowning in lawsuits like a bad Netflix drama. 📉 The FDA smackdown sent this biotech into a tailspin, and now ambulance-chasing lawyers are circling. Technically? RSI is flirting with oversold (36.5), but the 9-EMA is still nosediving below the 21-EMA—classic bearish vibes. Volume spikes on down days scream panic. Until the legal dust settles and the NDA resubmission proves legit, this feels like a SELL. #BiotechBruised"

"Yikes, ALDX is drowning in lawsuits after that FDA smackdown! 📉 The stock’s been bleeding, with RSI stuck in the oversold basement (hello, 36-ish) and WMAs screaming 'death cross' vibes. Volume’s erratic—like traders panicking between hope and despair. Chart? Ugly. Unless you’re betting on a miracle NDA resubmission, this smells like a SELL. #BiotechBombshell 🔍"

**Analysis:** ALDX just got wrecked 🚨—dropping 75% after FDA rejection (again). The 10-day EMA nosedived below the 50-day, confirming bearish momentum. RSI at 18.4 screams oversold 📉, but with lawsuits and negative news swirling, this isn’t a typical bounce candidate. Wild intraday swings (1.18–1.78) and massive volume (21.8M vs. avg ~2M) suggest panic selling. Hold off buying—this needs stabilization. If you’re in, watch for a base forming. Otherwise, steer clear until the dust settles. 💥 #BiotechVolatility